glutathione in ovarian cancer a double-edged sword

glutathione in ovarian cancer a double-edged sword Targeting ferroptosis cancer: Novel strategies to overcome chemotherapy resistance Redox-Regulated Iron Metabolism and Ferroptosis

Name: glutathione in ovarian cancer a double-edged sword Targeting ferroptosis cancer: Novel strategies to overcome chemotherapy resistance Redox-Regulated Iron Metabolism and Ferroptosis
Brand: msw-creativ-solutions.de
SKU: 27314239286
Price: 20.37 USD
Availability: InStock
Rating: 4.4419 (25 reviews)

Redox Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities Frontiers Targeting ferroptosis: a promising avenue for ovarian cancer treatment The crosstalk between glutathione metabolism and non coding RNAs in cancer progression and treatment resistance ScienceDirect N Acetyl Cysteine as a promising therapeutic approach in ovarian cancer: potential and perspectives PMC Frontiers Glutamine's double edged sword: fueling tumor growth and offering therapeutic hope Metabolic reprogramming of three major nutrients in platinum resistant ovarian cancer PMC

SKU: 27314239286 · From msw-creativ-solutions.de

4.4

USD20.37 USD70.37

Pay in 4 interest-free payments of $5.09 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 20 - Sep 25

Description

Firstly, we verified across a panel of normal and cancer cell lines with differing p53 status (Supplementary Table 1) that treatment with a lethal dose of APR-246 resulted in higher intracellular ROS (Fig

PHCs provided care to HCV treatment-nave patients with no or mild fibrosis (FIB-4 score 2-fold increased DAA susceptibility were analyzed

Of the patients with severe elevation in liver enzymes, n=19 (95%) occurred while critically ill in the ICU

doi: 10.3390/antiox12030548 92 LiJJiaYCDingYXBaiJCaoFLiF

doi: 10.1074/jbc.M009093200

Compared to healthy controls, SCD patients have significantly lower erythrocyte GSH and cysteine concentrations 12 and a faster rate of GSH synthesis, suggesting that the endogenous cysteine supply is insufficient to meet all anabolic demands